Sector: Health Care.Industry: Biotechnology
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics.
Earnings
see more| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-05-03 | ||||||
| REV | |||||||
| Q4 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-04-23 | ||||||
| REV | |||||||
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ATNF | 180 Life Sciences | 9.56% | 234.5M |
180 Life Sciences Company Questions & Answers
Q
How do I buy 180 Life Sciences (ATNF) stock?
A
You can purchase shares of 180 Life Sciences (NASDAQ: ATNF) through any online brokerage.
Q
Who are 180 Life Sciences's (ATNF) main competitors?
A
Other companies in 180 Life Sciences’s space includes: T2 Biosystems (NASDAQ:TTOO), Larimar Therapeutics (NASDAQ:LRMR) and Atossa Therapeutics (NASDAQ:ATOS).
Q
What is the target price for 180 Life Sciences?
A
There is no analysis for 180 Life Sciences
Q
How much is 180 Life Sciences (ATNF) stock ?
A
The stock price for 180 Life Sciences (NASDAQ: ATNF) is $9.74 last updated Fri Apr 09 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
Q
When is the next 180 Life Sciences (ATNF) dividend?
A
There are no upcoming dividends for 180 Life Sciences.
Q
When is 180 Life Sciences (NASDAQ:ATNF) reporting earnings?
A
180 Life Sciences’s Q1 earnings are confirmed after-market from now on May 3, 2021.
Q
When is the upcoming split for ATNF?
A
There is no upcoming split for 180 Life Sciences.